A Case of Severe Vedolizumab-induced Liver Injury

Inflamm Bowel Dis. 2021 Nov 15;27(12):e148-e149. doi: 10.1093/ibd/izab160.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Chemical and Drug Induced Liver Injury, Chronic*
  • Gastrointestinal Agents* / adverse effects
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab